In a landmark achievement, Fredun Pharmaceuticals Limited has been voted and awarded as India’s Most Innovative Pharmaceutical Company in Patient-Care Management 2024 at the prestigious 16th Annual Pharma Leaders Healthcare Super Brand Awards 2024. The award ceremony took place on Friday, December 20, 2024, at the Hilton Hotel in Mumbai, recognizing the company’s leadership and innovation in the Indian pharmaceutical market.
Fredun Pharmaceuticals Limited has demonstrated exceptional growth and innovation over the past year, launching 19 new products under its Cosmeceuticals OEM Division in 2023. Additionally, the company introduced 14 new products in the pet pharmaceuticals line, with another 36 in development. Fredun also made significant strides in the Pet Treat and Nutritional Supplement category, launching 16 new products that cater to the health and well-being of pets.
The prestigious Award Trophy and Certificate of Excellence were presented by Padma Shri Dr. Mukesh Batra, Founder Chairman of Dr. Batra’s Healthcare, in the presence of Dr. Satya Brahma, Founder and Chairman of Network 7 Media Group. The selection process was meticulously conducted by the independent agency Network 7 Research, ensuring the highest standards of evaluation.
This recognition underscores Fredun Pharmaceuticals Limited’s commitment to advancing patient care and innovation in the pharmaceutical industry, solidifying its position as a leader in the field.
Fredun Pharmaceuticals Ltd. is a pharmaceutical company located in Mumbai, India. With 27 years of experience in manufacturing pharmaceutical formulations, the company has established a reputation as a reliable and ethical organization. Their customer base includes leading pharmaceutical companies in India, as well as buyers across Africa, South East Asia, and CIS countries. The company offers a wide range of products, including analgesics, antacids, anthelmintics, anti-bacterials, anti-diabetics, anti-inflammatory drugs, anti-malarials, anti-obesity drugs, anticoagulants, anticonvulsants, antidiarrheals, antidepressants, antifungals, antihistamines, antihypertensives, antivirals, appetite stimulants with multivitamins, bone modulating drugs, bronchodilators, calcium tablets, cardiovascular drugs, diuretics, impotence drugs, and laxatives. Fredun Pharmaceuticals Ltd. has also expanded into Surgicare Products, offering IV fluids, disposable syringes, IV cannulas, infusion sets, surgical gloves, cottons, and personal healthcare products. They also provide APIs and excipients, ensuring the quality of their products by using the best ingredients available in compliance with regulatory requirements and different pharmacopeia standards. Additionally, the company offers Direct Compressible Granules in various categories such as anti-bacterials, anti-diabetics, analgesics, antihypertensives, antacids, anti-ulcers, anti-emetics, anti-obesity drugs, cardiovascular drugs, cough suppressants, diuretics, impotence drugs, iron supplements, and urology products.
Fredun Pharmaceuticals Limited, a leading provider of Pharmaceuticals and innovative healthcare solutions for veterinary applications. Fredun Pharmaceuticals is coming up with a cutting-edge manufacturing facility in Palghar, Maharashtra, which will be dedicated to the production of functional foods for pets. Conceptualized and construction is underway, it will begin operations by the third quarter of FY26, this plant is poised to play a crucial role in addressing the nutritional needs and chronic health concerns of pets in India.
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India. With this strategic move, Fredun is poised to become one of the pioneers in the market, providing high-quality, in-house manufactured functional foods designed to meet the nutritional needs of pets. The factory is being constructed with the aim of achieving the highest accreditations in the industry, positioning it as a premier source for top veterinary companies worldwide. While prioritizing the production of Fredun Brands, the facility will also serve white labeling clients for both the domestic and export markets, showcasing the company’s versatility and commitment to quality.
The pet care industry in India has witnessed exponential growth, and Fredun Pharmaceuticals is strategically positioned to capitalize on this trend. The company’s investment in the new plant is expected to significantly contribute to the growth of its pet care segment, further strengthening its market position.
Commenting on the Development, Fredun Medhora, Managing Director, said: “Our new functional food factory will not only be state-of-the-art but will also concentrate on crafting products that safeguard against chronic diseases, shaping a healthier tomorrow for pets and their owners. We recognize the evolving needs of Indian pet parents and are committed to meeting these with our innovative solutions. Machinery procurement is already in progress, and we are on track to be fully operational by Q3 FY26. This expansion is not just about growth; it’s about our responsibility to pet health and the trust that pet parents place in us.”
